A citation-based method for searching scientific literature

Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park, Jeong-Sun Seo. Cancer 2016
Times Cited: 89



Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
Times Cited: 363




List of shared articles



Times cited

Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Tihana Ibrahimpasic, Bin Xu, Iñigo Landa, Snjezana Dogan, Sumit Middha, Venkatraman Seshan, Shyam Deraje, Diane L Carlson, Jocelyn Migliacci, Jeffrey A Knauf,[...]. Clin Cancer Res 2017
53

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Lewis Hassell. Clin Endocrinol (Oxf) 2017
48

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.
Haoyu Ren, Yifan Shen, Daixing Hu, Wei He, Jing Zhou, Yijia Cao, Yu Mao, Yi Dou, Wei Xiong, Qi Xiao,[...]. Cancer Manag Res 2018
19

Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
Abdul K Siraj, Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Nabil Siraj, Sarah Siraj, Mark Ranier F Diaz, Dionne Rae Rala, Allianah D Benito, Maria Angelita Sabido,[...]. Genomics 2020
2

TERT promoter mutations and long-term survival in patients with thyroid cancer.
Tae Hyuk Kim, Young-Eun Kim, Soomin Ahn, Ji-Youn Kim, Chang-Seok Ki, Young Lyun Oh, Kyunga Kim, Jae Won Yun, Woong-Yang Park, Jun-Ho Choe,[...]. Endocr Relat Cancer 2016
46

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
24

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
3

A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.
Anello Marcello Poma, Riccardo Giannini, Paolo Piaggi, Clara Ugolini, Gabriele Materazzi, Paolo Miccoli, Paolo Vitti, Fulvio Basolo. Endocr Connect 2018
9

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
34

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
Hyunju Park, Hyeong Chan Shin, Heera Yang, Jung Heo, Chang-Seok Ki, Hye Seung Kim, Jung-Han Kim, Soo Yeon Hahn, Yun Jae Chung, Sun Wook Kim,[...]. Mod Pathol 2021
0

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
80


Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Sylwia Szpak-Ulczok, Aleksandra Pfeifer, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Tomasz Tyszkiewicz, Marta Cieslicka, Daria Handkiewicz-Junak, Krzysztof Fujarewicz, Dariusz Lange,[...]. Int J Mol Sci 2020
3

Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
Zunfu Ke, Yihao Liu, Yunjian Zhang, Jie Li, Ming Kuang, Sui Peng, Jinyu Liang, Shuang Yu, Lei Su, Lili Chen,[...]. Oncol Rep 2018
6

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
72

Multiplatform molecular test performance in indeterminate thyroid nodules.
Mark A Lupo, Ann E Walts, J Woody Sistrunk, Thomas J Giordano, Peter M Sadow, Nicole Massoll, Ryan Campbell, Sara A Jackson, Nicole Toney, Christina M Narick,[...]. Diagn Cytopathol 2020
12

Molecular Alterations in Thyroid Carcinoma.
Mohamed Rizwan Haroon Al Rasheed, Bin Xu. Surg Pathol Clin 2019
10

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung. J Pathol Transl Med 2020
7

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Gustavo C Penna, Fernanda Vaisman, Mario Vaisman, Manuel Sobrinho-Simões, Paula Soares. Cytogenet Genome Res 2016
32

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, Young Joo Park. Thyroid 2017
66

TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
Claire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, Julien Berthiller, Christelle de la Fouchardière, Anne-Laure Giraudet, Mireille Bertholon-Gregoire, Philip Robinson, Jean-Christophe Lifante, Jonathan Lopez,[...]. Eur J Cancer 2019
23

Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Shikha Bose, Wendy Sacks, Ann E Walts. Adv Anat Pathol 2019
9

A six-genotype genetic prognostic model for papillary thyroid cancer.
Xiaopei Shen, Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2017
41

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
36

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Dagmara Rusinek, Ewa Chmielik, Jolanta Krajewska, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Agnieszka Czarniecka, Barbara Jarzab. Int J Mol Sci 2017
19

Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2020
2

Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
Emma Scott, Diana Learoyd, Roderick J Clifton-Bligh. Future Oncol 2016
10

Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
23

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
Brittany A McKelvey, Christopher B Umbricht, Martha A Zeiger. Front Endocrinol (Lausanne) 2020
6

Application of molecular biology of differentiated thyroid cancer for clinical prognostication.
Vincenzo Marotta, Concetta Sciammarella, Annamaria Colao, Antongiulio Faggiano. Endocr Relat Cancer 2016
19

The Solo Play of TERT Promoter Mutations.
François Hafezi, Danielle Perez Bercoff. Cells 2020
8


How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Marco Dell'Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz,[...]. Cancer Cytopathol 2021
0

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.
Sevim Dalva-Aydemir, Cemaliye Boylu Akyerli, Şirin Kılıçturgay Yüksel, Hilal Keskin, Mustafa Cengiz Yakıcıer. OMICS 2019
3

Predictive factors of outcome in poorly differentiated thyroid carcinomas.
Christelle de la Fouchardière, Myriam Decaussin-Petrucci, Julien Berthiller, Françoise Descotes, Jonathan Lopez, Jean-Christophe Lifante, Jean-Louis Peix, Anne-Laure Giraudet, Armelle Delahaye, Sandrine Masson,[...]. Eur J Cancer 2018
27


Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.
Leila J Mady, Michael C Grimes, Nayel I Khan, R Harsha Rao, Simion I Chiosea, Linwah Yip, Robert L Ferris, Yuri E Nikiforov, Sally E Carty, Umamaheswar Duvvuri. Sci Rep 2020
2

The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.
Junyu Xue, Shiyong Li, Peijie Shi, Mengke Chen, Shuang Yu, Shubin Hong, Yanbing Li, Rengyun Liu, Haipeng Xiao. Front Oncol 2021
1


Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Michiya Nishino, Marina Nikiforova. Arch Pathol Lab Med 2018
40


Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma.
Riming Liu, Yulan Li, Weixin Chen, Jianglin Cong, Zhengfang Zhang, Li Ma, Lina Chu, Hui Xiao, Yanhong Zhang, Yongming Liu,[...]. Oncol Lett 2020
1

Genomic Characterization of Differentiated Thyroid Carcinoma.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2019
18

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Tomasz Trybek, Agnieszka Walczyk, Danuta Gąsior-Perczak, Iwona Pałyga, Estera Mikina, Artur Kowalik, Kinga Hińcza, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź,[...]. Endocrinology 2019
10

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.
Zhaowei Meng, Michiko Matsuse, Vladimir Saenko, Shunichi Yamashita, Peng Ren, Xiangqian Zheng, Qiang Jia, Jian Tan, Ning Li, Wei Zheng,[...]. IUBMB Life 2019
5


Not the same thing: metastatic PTCs have a different background than ATCs.
Dario de Biase, Federica Torricelli, Moira Ragazzi, Benedetta Donati, Elisabetta Kuhn, Michela Visani, Giorgia Acquaviva, Annalisa Pession, Giovanni Tallini, Simonetta Piana,[...]. Endocr Connect 2018
11

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18